STARS-ADHD

Pending FDA review and approval, research findings pave way for Akili’s EVO to become first brain training platform prescribed for ADHD

by

Akili Achieves Pri­ma­ry Effi­ca­cy End­point in ADHD Tri­al (MD magazine):

“Boston-based Akili Inter­ac­tive has announced top-line results from the STARS-ADHD piv­otal study of its inves­ti­ga­tion­al dig­i­tal ther­a­peu­tic med­i­cine AKL-T01, in treat­ment of pedi­atric atten­tion-deficit/hy­per­ac­tiv­i­ty dis­or­der (ADHD)…The dig­i­tal med­i­cine, AKL-T01, is a video game for patients to play on tablet devices. It uses the same sto­ry­telling and reward mech­a­nisms as stan­dard videogames; how­ev­er, it fea­tures mech­a­nisms to act on neur­al sys­tems and algo­rithms that dial the lev­el of stim­u­lus up or down, meet­ing the needs of the patient. [Read more…] about Pend­ing FDA review and approval, research find­ings pave way for Akili’s EVO to become first brain train­ing plat­form pre­scribed for ADHD